Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review.
JC Cogan, MM McFarland, JE May, MY Lim - Research and Practice in …, 2023 - Elsevier
Background Heparin-induced thrombocytopenia (HIT) is a relatively uncommon condition
characterized by two exceedingly common phenomena in hospitalized patients …
characterized by two exceedingly common phenomena in hospitalized patients …
Reducing inappropriate simultaneous ordering of heparin antibody and serotonin release assays
J Talledo, HJ Cho, D Alaiev, S Israilov… - The Joint Commission …, 2023 - Elsevier
Introduction A 4T score with intermediate or high probability of heparin-induced
thrombocytopenia prompts ordering of anti-platelet 4 heparin complex. If positive, a …
thrombocytopenia prompts ordering of anti-platelet 4 heparin complex. If positive, a …
Electronic Alerts to Improve Management of Heparin-Induced Thrombocytopenia
RL Zon, KW Sylvester, D Rubins, J Grandoni… - Research and Practice …, 2024 - Elsevier
Introduction Heparin-induced thrombocytopenia (HIT) is a difficult clinicopathologic
diagnosis to make and to treat. Delays in identification and appropriate treatment can lead to …
diagnosis to make and to treat. Delays in identification and appropriate treatment can lead to …
Hospitalized patients are needlessly over-tested for heparin induced thrombocytopenia
Heparin-induced thrombocytopenia (HIT) is an immune complication of heparin therapy
caused by antibodies to complexes of platelet factor 4 (PF4) and heparin. Patients with HIT …
caused by antibodies to complexes of platelet factor 4 (PF4) and heparin. Patients with HIT …